It may depend on where you are and where you are in your career.
Public health officials and activists call for action to reverse the rising U.S. maternal death rate.
Pharmacists should understand what Rh incompatibility during pregnancy is and how it is treated.
High-dose inactivated influenza vaccinations from community pharmacists during 2012-2013 flu season were more effective than standard-dose inactivated flu shots in patients 65 years and older, and helped in the prevention of influenza-associated hospitalizations, according to a comparative effectiveness study published in The Lancet Infectious Diseases.
FDA has approved two new HIV-1 cocktail drugs: elvitegravir (Vitekta, Gilead), an integrase inhibitor and cobicistat (Tybost, Gilead), a protease-inhibitor booster.
FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.
FDA has approved dulaglutide (Trulicity, Eli Lilly) to treat type 2 diabetes mellitus. The drug is a once-weekly subcutaneous injection used to improve glycemic control and is indicated as an adjunct to diet and exercise in the management of type 2 diabetes in adults.
Researchers from the Centers for Disease Control and Prevention (CDC) and FDA undertook a study to determine the most commonly implicated active ingredients responsible for childhood poisonings that required emergency hospitalization in the hope of identifying prevention and intervention strategies. Buprenorphine and clonidine were the most common of 12 active ingredients that were found in 45.0% of these hospitalizations.
Proposed legislation that would cover home-based infusion therapy for Medicare beneficiaries could save the healthcare system approximately $80 million over 10 years and provide access to life-saving care at patients’ homes. The potential savings is outlined in a report released in June by Avalere.
NOH is a rare, chronic, and debilitating drop in blood pressure upon standing. It is associated with Parkinson's disease, multiple system atrophy, and pure autonomic failure.